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Abstract 
Serum free fermentation procedures of cell cultures have got a wide application in production of 
biochemicals. But, cells cultured in serum free media in general are more sensitive to changes in culture 
condition, especially to nutrient limitation. There are no substances from serum which can support he 
cells when conditions are changing. In this study special attention is directed to amino acid utilization of
mouse hybridoma in batch, chemostat and perfusion fermentations. Detailed data are presented which 
show the considerable difference of amino acid consumption rates in different fermentation modes. 
Already, in batch mode there are differences of the two investigated mouse hybridoma cell lines, 
although they are derived from the same myeloma line. In chemostat running at a dilution rate 
representing maximal growth rate most of the consumption rates are significant higher than in batch. On 
the other hand, in perfusion mode the rates are lower than in batch. This indicates clearly the different 
conditions of the fermentation modes. Therefore, it is necessary to develop serum free processes under 
the desired production conditions. An accurate anaylsis of the process is strongly recommended. 
Introduction 
Mammalian cell culture becomes more and more 
important for the production of special biophar- 
maceuticals and biodiagnostics not only in re- 
search but also in clinical diagnostic and therapy. 
The products which are produced for direct appli- 
cation to man have to be of extremely high purity 
and constant quality. To guarantee this standard a 
well defined production method has to be estab- 
lished and also all raw materials which are used 
in the process have to be of constant quality. 
In many processes several serum compositions 
(fetal calf serum, newborn calf serum, horse 
serum, human serum) are used. Serum contains 
many proteins, peptides, growth factors, hor- 
mones and other components which may be of 
importance for the cells to be cultivated. But, the 
concentrations of these components differ from 
charge to charge. Therefore, each charge can 
have a different ability for promoting cell growth 
and product formation. The use of a totally de- 
fined serum free medium can overcome this 
problem if it is possible to adapt he cells to this 
conditions without loss of productivity (Takaza- 
wa et al., 1988). 
The importance of serum for basic nutrition 
(e.g., glucose, amino acids) is low if it is used in 
contents of 5-10% of the complete medium. 
Serum contains almost all amino acids (Table 1) 
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Table 1. Amino acid content of fetal calf serum (Boehringer 
Mannheim, Germany), analysed with the method described in 
this study 
Amino acid Concentration 
gmol L -1 
ALA 1198 
ASP 77 
GLN 747 
GLU 371 
GLY 770 
HIS 87 
ILE 146 
LEU 277 
LYS 161 
MET 31 
ORN 210 
PHE 129 
SER 310 
THR 274 
TRP 69 
TYR 101 
VAL 333 
Bioreactor systems 
For the production of monoclonal antibodies a
wide variety of technical systems are available. 
The most used systems are stirred reactors in 
different modes: batch, chemostat or perfusion. 
As an advantage of homogeneous suspension 
cultures the cells and their behaviour are easy to 
observe. At every time it is possible to get repre- 
sentative samples to analyse nutrients and cell 
numbers. 
ha chemostat culture the cell density is much 
lower than in perfusion culture but in perfusion 
culture sufficient feeding of all nutrients general- 
ly is more difficult, because of the high cell 
density and the low concentration f some amino 
acids in commercially available culture media. 
Therefore, the concentrations of the nutrients 
have to be monitored and analysed carefully. 
Two examples for the cultivation in these 
modes are discussed below. 
but the concentrations are not as high as it can 
work as pool for amino acids. Nevertheless, there 
is a pool of useful substances in serum which can 
support the cells under culture conditions. These 
substances are not existing in serum free medium. 
Therefore, serum free cultures are more sensible 
to changes in culture conditions. Especially nu- 
trient limitation can cause changes in cell be- 
haviour in respect o process stability. Cell spe- 
cific parameters (growth rate, nutrient consump- 
tion rates) can help to characterize the cell status. 
Unfortunately, these parameters are not constant 
for one cell line. They are affected by the culture 
conditions (e.g., pH, T, p02, agitation) and by the 
fermentation method (e.g., batch, fed batch, che- 
mostat, perfusion, dense cell system). For the 
development and optimization of a production 
process it is necessary to analyse as much para- 
meters as possible under the desired production 
conditions. 
In this study the changes of nutrient require- 
ments, especially amino acids, of two mouse 
hybridoma cell lines in different fermentation 
modes are shown and discussed. 
Chemostat reactor 
The chemostat reactor used in this study was a 
Biostat BF with 2 L stirred culture vessel (B. 
Braun, Melsungen, Germany) equipped with a 
membrane stirrer with 2 m polypropylene hollow 
fibre membrane tubing per litre for bubble free 
aeration (Lehmann et al., 1988). The medium 
exchange was carried out using two peristaltic 
pumps (Watson-Marlow 501-UR). Temperature 
was set to 37~ pH to 7.2 and pO2 to 40% air 
saturation. 
Perfusion reactor 
This 2 L reactor (the same as above) was equipped 
with a membrane basket with 2 m silicone tubing 
per litre for aeration and 2 m hydrophilized 
polypropylene hollow fibre membrane tubing per 
litre for medium exchange. The microfiltration 
membrane (0.3 gm) was connected at the input 
side via a peristaltic pump (Watson-Marlow 501- 
UR) with the medium reservoir and at the output 
side via another pump with the harvest tank. 
These two perfusion pumps run alternatively con- 
trolled by a system creating a process cycle of 
harvesting and feeding depending on reactor vol- 
ume and pump speed. Running this cycle perfu- 
sion was carried out (Btintemeyer 1988). Addi- 
tionally, a third pump was connected to the reac- 
tor directly for cell harvest. It was necessary to 
remove cells from the reactor to reach steady 
state conditions (Btintemeyer et al. 1987). Phy- 
siological setpoints (pH, pO2, T) were set to the 
same values as in the chemostat experiments. 
Materials and methods 
Cells 
The cell lines used in this study were mouse 
hybridoma (mouse myeloma P3X63-Ag8.653 
subclone/BALB/c) secreting monoclonal anti- 
bodies (K6hler and Milstein, 1975). The cell line 
GL3 used in the perfusion reactor secreted a 
monoclonal antibody against gelsolin. For the 
chemostat experiments the mouse hybridoma 
VIN2 producing a monoclonal antibody against 
vinculin was used. These two antigens are pro- 
teins of the cytoskeleton of mammalian cells 
(Jockusch et al. 1986). Both cell lines were 
kindly supplied by Prof. Dr. B.M. Jokusch, De- 
partment of Biology, University of Bielefeld. 
Cell numbers were determined microscopically 
by trypan blue exclusion. 
Me~um 
The serum free medium was a 1:1 mixture of 
IMDM and Ham's F12 supplemented with 2 mM 
L-glutamine, 2 mM pyruvate, 20 p-M ethanol- 
amine, 1 g/L bovine serum albumin complexed 
with 4 mg oleic acid, 10 mg/L human transferrin 
(Fe saturated), 10 mg/L bovine insulin (J/iger et 
al., 1988). The medium and the supplements 
were sterilized by membrane filtration (0.2 
p.m). 
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Amino acid analysis 
The free amino acids in the samples of the 
fermentations were analysed using an automated 
reversed phase high performance liquid chroma- 
tographic system (RP-HPLC) with precolumn 
derivatization using the OPA method. 
The HPLC system was a Kontron D 450 system 
consisting of two HPLC pumps type 420, an 
autosampler type 460, a fluorometer SFM 25 and 
a data system MT 450. 
Sample preparation 
All samples from fermenter or culture flask ori- 
gin were centrifuged for 5 min (1500 x g) to 
remove all cells and debris. For the removal of 
the proteins 50 p-L of the supernatant were mixed 
with the same volume of 3% perchloric acid in 
water containing also 300 p-M 13-alanine as inter- 
nal standard. This solution was centrifuged 3 min 
(14500 x g). 50 gL of the supernatant were mixed 
with 100 p-L of sodium borate buffer (0.4 M, pH 
9.5) to guarantee a pH above pH 8. 10 p-L of this 
solution was filled into a special autosampler vial 
for automatic processing. 
Derivatization procedure (OPA method) 
The derivatization solution was prepared by dis- 
solving 100 mg o-phthaldialdehyde (OPA) and 
100 p-L 2-mercaptoethanol in 1.5 mL methanol 
and filled up with sodium borate buffer (0.4 M 
pH 9.5) to a final volume of 7 mL. This solution 
is stable for 2 days at room temperature. The pH 
of 9.5 is necessary for the derivatization of the 
amino acids with o-phthaldialdehyde to guaran- 
tee a not protonized primary amino group. 
The derivatization of the free amino acids in the 
prepared sample solution was carried out automa- 
tically by the autosampler system. 
80 p-L of the OPA solution was filled into the 
sample vial and mixed for 30 secs. The total 
reaction time was set to 1.5 min. After that time 
15 gL were injected onto the column. 
HPLC conditions 
For the separation and quantification of all amino 
acids a binary multi step gradient system was 
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necessary (Bober 1986; Btintemeyer 1988; Wag- 
ner et al. 1988). 
Buffer A: 
85% sodium acetate pH 6.5 
14% methanol 
1% tetrahydrofuran 
Buffer B: 
20% sodium acetate pH 6.0 
80% methanol 
Each complete analysis including derivatization, 
column washing, equilibration and calculation 
takes a time of 60 min. Fig. 1 represents a
standard run. 
HPLC columns 
The HPLC column was a Beckman Ultraphere 
ODS 5 g, 250 x 4.6 nun, (Beckman, Mfinchen, 
Germany) reversed phase column set to a tem- 
perature of 22~ using a water jacket and a 
thermostat. To prevent a fast fouling of the col- 
umn a guard column filled with RP material 
Shandon ODS Hypersil 10 g, 10 x 4.6 mm, 
(Techlab, Erkerode, Germany) was placed in 
front of the main column. 
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Fig. 1. HPLC calibration run with all detectable amino acids in 
concentrations representing a 1:1 mixture of cell culture media 
IMDM and F12 except LYS (two fold concentration) and ORN 
(occurs not in IMDM/F12, concentration like LYS). 
1 = ASP, 2 = GLU, 3 = ASN, 4 = SER, 5 = HIS, 6 = GLN, 7 = 
GLY, 8 = THR, 9 = ARG, 10 = 13-ALA (intemal standard), 11 = 
ALA, 12 = TYR, 13 = TRP, 14 = MET, 15 = VAL, 16 = PHE, 
17 = ILE, 18 = LEU, 19 = ORN, 20 = LYS. 
Standardization 
Stock solutions of all primary amino acids which 
occur in cell culture media were prepared by 
dissolving the substances (analytical grade) in 
purified water (Milli-Q, Millipore). These stock 
solutions were aliquoted and stored at -20~ 
From those stock solutions aready-to-inject solu- 
tion was prepared just before analysis. This solu- 
tion contained the amino acids in such concentra- 
tions as in the used medium composition. 
Calculation and quantification 
Calibration factors were calculated from standard 
runs. Sample quantification was carried out using 
the internal standard method, g-alanine was used 
as internal standard because it does not appear in 
animal cell metabolism. 
The reproducibility of the calculated amino 
acid concentrations f the supematant using this 
internal standard method was better than 5% for 
each amino acid except of lysine, because of the 
low fluorescence r sponse of its OPA derivate. 
Glucose and lactic acid analysis 
Glucose and lactic acid concentrations were ana- 
lysed using an automatic analyser system based 
on enzymatic and electrochemical reactions (YSI 
2000, Yellow Springs Instruments, OH, USA). 
Antibody concentration 
Antibody concentrations in the supematant were 
analysed by a kinetic sandwich ELISA method. 
The enzyme linked to the antibody (goat anti 
mouse antibody) was peroxidase converting o- 
phenylenediamine as substrate. For the kinetic 
analysis in each microplate well (standards and 
samples) an experimental point was taken every 3 
minutes to control the complete nzyme reaction. 
In the linear part of this conversion curve (extinc- 
tion versus time) the slope was calculated and 
correlated to the content of the standard solution. 
From this calibration function sample concentra- 
tions of several dilution steps were calculated. 
Chemicals 
Water for fermentation and HPLC was prepared 
by a Milli-Q system (Millipore, Bedford, MA, 
USA). All chemicals were of analytical grade. 
Organic solvents (methanol, tetrahydrofuran) 
were purchased from Baker (Philipsburg, NJ, 
USA), cell culture media from Gibco (Paisley, 
UK). All other chemicals were purchased from 
Sigma (St. Louis, MO, USA) except bovine se- 
rum albumin, glutamine (Serva, Heidelberg, Ger- 
many), o-phthalaldehyde, o-phenylenediamine 
(Aldrich, Steinheim, Germany) and antibodies 
for ELISA (Medac, Hamburg, Germany). 
Results 
For the determination of cell specific parameters 
the two hybridoma cell lines GL3 and VIN2 were 
cultivated in different modes. Hybridoma VIN2 
was cultivated in batch and chemostat mode, 
hybridoma GL3 in batch and perfusion mode 
with cell harvest. For the comparison of the two 
cell lines and cultivation methods pecific para- 
meters for cell growth, substrate utilization and 
product formation were calculated following the 
equations listed below (Pirt, 1985). 
Equations fo r  the calculation o f  cell specific 
parameters 
I. Batch: 
Cell growth: 
1 dx 
x dt 
[d -1] [1] 
Specific substrate utilization: 
1 dc s 
QS ~"  - -  " - -  
x dt 
[mole/cells 9d] [2] 
Growth yield: 
g 
YX/S  ~ - -  
qs 
[cells/mole] [3] 
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Specific production: 
1 dp 
qp ~ - -  . _ _  
x dt 
[g/cells 9 d] [4] 
II. Chemostat: 
Cell growth: 
dx 
= gx-Dnx  
dt 
Specific substrate utilization: 
dc s 
= D(Co - Cs) - qsx 
dt 
Specific production: 
dp =%-Dp 
dt 
[5] 
[6] 
[7] 
III. Perfusion: 
Cell growth: 
dx 
=gx 
dt 
Specific substrate utilization: 
dcs 
= De(co - Cs) - qsX 
dt 
[8] 
[9] 
Specific production: 
dp 
= qp - Dp  [10] 
dt 
IV. Perfusion with cell harvest (mixed perfusion 
and chemostat) 
Cell growth: 
dx 
= gx - DHX 
dt 
[11] 
62 
Specific substrate utilization: 
dc  s 
= D(co - Cs) - qsX [12] 
dt 
Specific production: 
dp 
= qp - Dp  [13] 
dt 
Symbols  
x viable cell density [cells/mL] 
t time [d] 
specific growth rate [d -1] 
c s substrate concentration [mole/L] 
c o substrate medium concentration [mole/L] 
qs specific substrate utilization rate [mole/cells 9d] 
p product concentration [g/L] 
qp specific production rate [g/ceils 9 d] 
Y growth yield [cells/mole] 
D total dilution rate D = D H + Dp [d -1] 
D H cell harvest rate [d -1] 
Dp perfusion rate [d -1] 
Ca lcu la t ion  procedure  
For the calculation of all amino acid consumption 
rates in the batch phase it was necessary to have a 
reference (Table 2). The reference time for batch 
mode was set to the latest ime when g = ~max 
before g decreases. For this purpose a function 
was correlated mathematically to the cell prolif- 
eration curve. From the first order derivative 
(dx/dt) of this function a ~t(t) curve was calcu- 
lated using equation (1). An example for the 
batch phase of GL3 is displayed in Fig. 2. 
The specific rates of all nutrients were calcu- 
lated in a similar way using equation (2). From 
Fig. 3 it can be seen that qs is not constant. Table 3 
Table 2. Cell specific parameters ~trnax and qp for both hybrido- 
ma cell lines (calculated from each batch phase) 
Cell line VIN2 GL3 
]-tma x [d -1] 1 0.63 
qp [gg" 10-6cells.d -1] 4 5 
m 
O) 
o o .6  
0.6 
B 8 "r 8 
Cultivation T ime (d) 
0 V iab le  Cel ls  - -  Cor re la t ion  Curve  .m ~ (L) 
Fig. 2. Estimation of the time course of function ~t(t). Ix was 
calculated in the batch phase of the fermentation of hybridoma 
GL3. 
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Fig. 3. Specific consumption rate of leucine as a function of 
time, calculated in the batch phase of fermentation of hybrido- 
ma GL3. 
summarizes all values calculated for both cell 
lines. The specific rates listed in the batch 
columns are related to the reference time of the 
indicated batch fermentation. 
All specific parameters in chemostat or perfu- 
sion mode were calculated with the correspond- 
ing equations (5-13) under steady state condi- 
tions when 
dx =0,  des =0, __dP =0. 
dt dt dt 
The results are listed also in Table 3. 
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Table 3. Specific consumption rates qs of all amino acids, glucose and lactic acid for both estimated hybridoma cell lines (VIN2, GL3). 
All values are given in nmol.10-6cells.d -1 
Cell line VIN2 GL3 
substrate 
Batch Chemostat Batch Perfusion 
ASP 54.8 103.6 31.3 0.9 
GLU 29.1 190.0 55.1 -7.7 
ASN 52.1 48.2 48.0 26.1 
SER 231.8 109.5 57.6 -86.9 
GLN 3595.3 2075.9 1323.1 1162.4 
GLY 72.1 303.4 36.8 40.0 
THR 128.7 197.5 101.9 116.3 
ARG 199.3 203.9 144.0 64.7 
ALA -400.8 -878.6 -2121.0 -562.8 
TYR 95.7 189.1 65.4 41.1 
TRP 17.0 11.8 13.9 10.9 
MET 55.1 80.7 38.7 42.7 
VAL 143.7 279.4 128.7 115.4 
ILE 75.7 245.1 129.7 129.3 
LEU 41.1 312.5 167.2 135.7 
LYS 54.5 292.1 30.3 7.3 
Glucose 8035.91 8163.0 1690.6 1631.4 
Lactic acid -8558.6 -11009.0 -675.5 -1052.9 
Chemostat fermentation 
The cells, secreting a monoclonal antibody 
against vinculin, were cultivated over a period of 
20 days. During the first three days the cells grew 
from 2 • 105 cells/mL up to 3 • 106 cells/mL in 
1E+07-  - 20  
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Fig. 4. Time course of the fermentation of hybridoma VIN2. 
Shown are the courses of viable cell density, glucose and 
antibody concentrations. First batch phase till day 3, second 
batch phase from day 3 to day 5, chemostat phase from day 5 to 
day 20. 
batch mode. Then the cells died, because of 
nutrient limitation. After diluting the fermenta- 
tion suspension with fresh medium the cells started 
to grow again (Fig. 4). Beginning at day 5, the 
chemostat was started with a dilution rate of D = 
1 d -1. During the following 15 days the cell 
density was kept at 1.3-1.8 x 106 cells/mL. At 
this time almost all amino acid concentrations 
were constant at a low level except alanine which 
was produced by the cells. From the amino acid 
content of the medium and the calculated specific 
consumption rates it was obvious that methionine 
would be the first amino acid running into limita- 
tion. The methionine concentration did not fall to 
zero but was constant at a level of 25 ~tmol/L 
(Fig. 5). The steady state viable cell density was 
1.35 x 106 cells/mL. Beginning at day 9 of the 
fermentation the feeding medium was supple- 
mented with methionine and tryptophan in  the 
way that the new concentrations were twice the 
time of the original medium concentration. This 
resulted in a small increase of steady state viable 
cell density to a level of 1.65 x 106 cells/mL 
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Fig. 5. Amino acid concentration during the chemostat fermen- 
tation of hybridoma VIN2. Shown are the concentrations of the 
amino acids TRP, MET, VAL, ILE, LEU beginning at day 3 
with a 2 days batch phase, continuing with the chemostat phase. 
From the day 9 the methionine and tryptophan concentrations 
were doubled in respect to the basal medium. 
indicating another amino acid limitation (ILE). 
There was no effect on viable cell density by 
increasing the isoleucine concentration in the 
feeding medium, because most of the amino acids 
had a growth yield Yx/s of about 1.7 x 10 6 
cells/gmole (data not shown here). The specific 
antibody production during the batch phase was 
quite the same as during the chemostat phase and 
was amounted to 4 ~tg • 10 -6 cells • d -I. 
P erfusion fermentation 
The fermentation of the hybridoma cell line GL3, 
secreting a monoclonal antibody against gelsolin, 
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Fig. 6. Time course of the first part of the fermentation of 
hybridoma GL3. Shown are viable and death cell concentrations 
and glucose concentration during the batch phase of the fermen- 
tation. 
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Fig. 7. Time course of amino acid consumption of VAL, ILE, 
LEU, MET during batch phase of the fermentation of hybrido- 
ma GL3. 
was subdivided into two parts: first part batch; 
second part perfusion with cell harvest. 
In the first part (Figs. 6 and 7) when the rates 
of consumption of all nutrients were calculated 
(Table 3), the cells grew up to a density of 1.8 • 
10 6 cells/mE Then the cells died, because of the 
limitation of amino acids (glutamine, methio- 
nine); glucose concentration was not important in 
this period. Then half of the volume of the 
fermenter was drained off and filled up again 
with fresh medium to start part two of the fer- 
mentation. The cells grew again and in this sec- 
ond part (Fig. 8) of the fermentation the fermen- 
ter was fed with fresh medium as described above 
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Fig. 8. Time course of the perfusion phase of the fermentation 
of hybridoma GL3. Shown are viable cell density, glucose 
concentration and antibody yield during this phase. Perfusion 
rate Dp and celt harvest rate D H also are displayed for continu- 
ous phase. 
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Table 4. Amino acid concentrations of basal (1:1 mixture HAM's F12 and IMDM) and perfusion medium (basal medium with addition 
of selected amino acids) 
Amino acid Basal medium ~t ol/L Perfusion medium ~tmol/L 
ASP 162.7 162.7 
GLU 304.9 304.9 
ASN 144.6 289.2 
SER 249.7 249.7 
GLN 2500 7500 
GLY 499.3 499.3 
THR 448.8 448.8 
ARG 700 700 
ALA 190.2 190.2 
TYR 309 309 
TRP 44.2 88.4 
MET 115.5 346.5 
VAL 450.9 901.8 
ILE 415.2 830.4 
LEU 450.1 900.2 
LYS 499.5 499.5 
HIS 150.2 225.3 
PHE 218.7 437.4 
(perfusion procedure). The feeding rate was raised 
from Dp = 0.8 d -1 at the beginning, up to a 
max imum of Dp = 1.7 d-l; then cell harvest was 
started. Further changes of Dp were necessary to 
stabilize the steady state. The medium used in 
this part was optimized by supplementation f the 
limiting amino acids. The concentrations of as- 
paragine, tryptophan, valine, isoleucine, leucine 
and phenylalanine were double, methionine and 
glutamine were triple and histidine was one and a 
half the time in respect to the basal medium, 
respectively (Table 4). 
With this medium it was possible to supply 1 x 
107 cells/mL. At 1 x 107 cells/mL cell harvest 
was started to reach a steady state. During the rest 
of the fermentation 0.5-0.7 L x d -1 fermentation 
suspension were removed to keep the steady state 
constant. For a period of 20 days this steady state 
was kept at a viable cell density of approx. 7 x 
106 cells/mL. The amino acid concentrations in
this period were constant, also indicating that a 
steady state point was really reached (Fig. 9). 
These steady state conditions of optimal supply 
led to an antibody production of 8 ~g x 10 -6 cells 
x d_ 1. This was remarkable higher than the pro- 
ductivity of 5 [.tg x 10 -6 cells x d -1 observed in 
batch culture during exponential growth. 
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Fig. 9. Amino acid concentrations during the steady state of the 
perfusion phase of the fermentation f hybridoma GL3. Dis- 
played are the four amino acids VAL, ILE, LEU and MET. 
Discussion 
From the data of the two fermentation it is 
obvious that amino acid concentrations in serum 
free medium are of tremendous importance for 
growth and production in animal cell cultures 
(Eagle t959). The glucose concentration is not as 
interesting as some selected amino acid concen- 
trations. For the development of a production 
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system it is strongly recommended to optimize 
under the desired fermentation mode, because 
nutrient consumption can change dramatically by 
switching from mode to mode. 
In the fermentations discussed above, gluta- 
mine and especially methionine were of high 
importance for both cell lines (Arwadi et at. 
1984; Zielke et al. 1984). The calculation of 
amino acid consumption rates made it possible to 
compare both cell lines. Furthermore, this calcu- 
lation gave the opportunity to optimize the me- 
dium for the perfusion fermentation, which was 
the premise for the high density cultivation of 
these cells. 
In comparison, the consumption rates of both 
cell lines in batch phase are of same order except 
glucose and some of the amino acids. The cell 
line VIN2 uses much more glucose and gluta- 
mine for energy requirement leading to a higher 
growth rate but not o a higher production rate. 
The consumption rates in chemostat phase of 
VIN2 are in most cases twice as high as in batch 
phase. The reason for this effect possibly is wash 
out of waste products and inhibitors and that 
constant conditions resulting in a chemostat 
growth rate of gma• These good conditions do 
not result in a higher productivity. The first 
limiting substance in chemostat culture was me- 
thionine, already expected from consumption rate 
and medium content. 
In the perfusion experiment using cell line 
GL3 the situation is quite different from chemo- 
stat culture of VIN2. In most cases the consump- 
tion rates are lower than in the related batch 
phase. Steady state growth rate also is lower than 
gmax, but productivity is higher. This can be 
caused by cell interaction, self conditioning ef- 
fects and good nutrition supply (Duval et al. 
1989; Geaugey et al. 1989). 
A very interesting amino acid is serine. During 
VIN2 fermentation the consumption rate de- 
creased switching from batch to chemostat mode. 
In perfusion mode of GL3 fermentation it is 
already produced. In contrast to these results 
human lymphoid cells are strongly dependent on 
serine, also in high cell density culture (Birch et 
al. 1977; Btintemeyer 1988). 
Following conclusions can be taken: 
- a better antibody harvest is obtained by perfu- 
sion fermentation; 
- medium optimization is necessary for high 
density culture; 
- monitoring of amino acid consumption is very 
helpful; 
- process development for the desired produc- 
tion mode is recommended. 
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